nodes	percent_of_prediction	percent_of_DWPC	metapath
Alclometasone—NR3C1—hematologic cancer	0.0764	1	CbGaD
Alclometasone—Corticosteroid Hormone Receptor Agonists—Betamethasone—hematologic cancer	0.0692	0.209	CiPCiCtD
Alclometasone—Corticosteroid Hormone Receptor Agonists—Dexamethasone—hematologic cancer	0.0692	0.209	CiPCiCtD
Alclometasone—Corticosteroid Hormone Receptor Agonists—Triamcinolone—hematologic cancer	0.0668	0.202	CiPCiCtD
Alclometasone—Corticosteroid Hormone Receptor Agonists—Prednisolone—hematologic cancer	0.0647	0.195	CiPCiCtD
Alclometasone—Corticosteroid Hormone Receptor Agonists—Prednisone—hematologic cancer	0.0611	0.185	CiPCiCtD
Alclometasone—Dexamethasone—hematologic cancer	0.0501	0.208	CrCtD
Alclometasone—Betamethasone—hematologic cancer	0.0501	0.208	CrCtD
Alclometasone—Triamcinolone—hematologic cancer	0.0489	0.203	CrCtD
Alclometasone—Prednisone—hematologic cancer	0.0464	0.193	CrCtD
Alclometasone—Prednisolone—hematologic cancer	0.0453	0.188	CrCtD
Alclometasone—SERPINA6—Triamcinolone—hematologic cancer	0.0225	0.171	CbGbCtD
Alclometasone—SERPINA6—Prednisolone—hematologic cancer	0.0191	0.145	CbGbCtD
Alclometasone—NR3C1—Triamcinolone—hematologic cancer	0.0105	0.08	CbGbCtD
Alclometasone—NR3C1—Betamethasone—hematologic cancer	0.00902	0.0686	CbGbCtD
Alclometasone—NR3C1—Prednisolone—hematologic cancer	0.0089	0.0677	CbGbCtD
Alclometasone—NR3C1—Prednisone—hematologic cancer	0.00841	0.064	CbGbCtD
Alclometasone—NR3C1—Dexamethasone—hematologic cancer	0.00525	0.0399	CbGbCtD
Alclometasone—CYP3A4—Bexarotene—hematologic cancer	0.00397	0.0302	CbGbCtD
Alclometasone—CYP3A4—Busulfan—hematologic cancer	0.00369	0.028	CbGbCtD
Alclometasone—CYP3A4—Lomustine—hematologic cancer	0.00369	0.028	CbGbCtD
Alclometasone—CYP3A4—Thiotepa—hematologic cancer	0.00329	0.025	CbGbCtD
Alclometasone—CYP3A4—Methoxsalen—hematologic cancer	0.00256	0.0194	CbGbCtD
Alclometasone—CYP3A4—Bortezomib—hematologic cancer	0.00243	0.0185	CbGbCtD
Alclometasone—CYP3A4—Daunorubicin—hematologic cancer	0.00232	0.0177	CbGbCtD
Alclometasone—CYP3A4—Cytarabine—hematologic cancer	0.00205	0.0156	CbGbCtD
Alclometasone—CYP3A4—Teniposide—hematologic cancer	0.00202	0.0154	CbGbCtD
Alclometasone—CYP3A4—Ifosfamide—hematologic cancer	0.00186	0.0142	CbGbCtD
Alclometasone—Ciclesonide—Prednisone—hematologic cancer	0.00186	0.0108	CrCrCtD
Alclometasone—Ciclesonide—Prednisolone—hematologic cancer	0.00182	0.0106	CrCrCtD
Alclometasone—Flurandrenolide—Dexamethasone—hematologic cancer	0.00179	0.0104	CrCrCtD
Alclometasone—Flurandrenolide—Betamethasone—hematologic cancer	0.00179	0.0104	CrCrCtD
Alclometasone—CYP3A4—Imatinib—hematologic cancer	0.00178	0.0135	CbGbCtD
Alclometasone—Flumethasone Pivalate—Dexamethasone—hematologic cancer	0.00173	0.0101	CrCrCtD
Alclometasone—Flumethasone Pivalate—Betamethasone—hematologic cancer	0.00173	0.0101	CrCrCtD
Alclometasone—Flumethasone Pivalate—Triamcinolone—hematologic cancer	0.00169	0.00984	CrCrCtD
Alclometasone—Fluticasone Propionate—Betamethasone—hematologic cancer	0.00168	0.00975	CrCrCtD
Alclometasone—Halobetasol Propionate—Dexamethasone—hematologic cancer	0.00168	0.00975	CrCrCtD
Alclometasone—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.00168	0.00975	CrCrCtD
Alclometasone—Halobetasol Propionate—Betamethasone—hematologic cancer	0.00168	0.00975	CrCrCtD
Alclometasone—CYP3A4—Ruxolitinib—hematologic cancer	0.00168	0.0128	CbGbCtD
Alclometasone—Halobetasol Propionate—Triamcinolone—hematologic cancer	0.00164	0.00953	CrCrCtD
Alclometasone—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.00164	0.00953	CrCrCtD
Alclometasone—Flurandrenolide—Prednisolone—hematologic cancer	0.00162	0.00944	CrCrCtD
Alclometasone—CYP3A4—Nilotinib—hematologic cancer	0.00162	0.0123	CbGbCtD
Alclometasone—CYP3A4—Vinorelbine—hematologic cancer	0.0016	0.0122	CbGbCtD
Alclometasone—Beclomethasone—Betamethasone—hematologic cancer	0.00158	0.00917	CrCrCtD
Alclometasone—Clocortolone—Betamethasone—hematologic cancer	0.00158	0.00917	CrCrCtD
Alclometasone—Beclomethasone—Dexamethasone—hematologic cancer	0.00158	0.00917	CrCrCtD
Alclometasone—Prednicarbate—Dexamethasone—hematologic cancer	0.00158	0.00917	CrCrCtD
Alclometasone—Prednicarbate—Betamethasone—hematologic cancer	0.00158	0.00917	CrCrCtD
Alclometasone—Clocortolone—Dexamethasone—hematologic cancer	0.00158	0.00917	CrCrCtD
Alclometasone—Prednicarbate—Triamcinolone—hematologic cancer	0.00154	0.00896	CrCrCtD
Alclometasone—Beclomethasone—Triamcinolone—hematologic cancer	0.00154	0.00896	CrCrCtD
Alclometasone—Clocortolone—Triamcinolone—hematologic cancer	0.00154	0.00896	CrCrCtD
Alclometasone—Fluocortolone—Dexamethasone—hematologic cancer	0.00153	0.00891	CrCrCtD
Alclometasone—Fluocortolone—Betamethasone—hematologic cancer	0.00153	0.00891	CrCrCtD
Alclometasone—Fluocortolone—Triamcinolone—hematologic cancer	0.0015	0.0087	CrCrCtD
Alclometasone—Fluocinolone Acetonide—Betamethasone—hematologic cancer	0.00149	0.00866	CrCrCtD
Alclometasone—Fluocinolone Acetonide—Dexamethasone—hematologic cancer	0.00149	0.00866	CrCrCtD
Alclometasone—CYP3A4—Triamcinolone—hematologic cancer	0.00147	0.0112	CbGbCtD
Alclometasone—Prednicarbate—Prednisone—hematologic cancer	0.00146	0.0085	CrCrCtD
Alclometasone—Fluocinolone Acetonide—Triamcinolone—hematologic cancer	0.00146	0.00846	CrCrCtD
Alclometasone—Budesonide—Betamethasone—hematologic cancer	0.00145	0.00843	CrCrCtD
Alclometasone—Budesonide—Dexamethasone—hematologic cancer	0.00145	0.00843	CrCrCtD
Alclometasone—CYP3A4—Dasatinib—hematologic cancer	0.00143	0.0109	CbGbCtD
Alclometasone—Prednicarbate—Prednisolone—hematologic cancer	0.00143	0.0083	CrCrCtD
Alclometasone—Clocortolone—Prednisolone—hematologic cancer	0.00143	0.0083	CrCrCtD
Alclometasone—Beclomethasone—Prednisolone—hematologic cancer	0.00143	0.0083	CrCrCtD
Alclometasone—Fluocortolone—Prednisone—hematologic cancer	0.00142	0.00826	CrCrCtD
Alclometasone—Budesonide—Triamcinolone—hematologic cancer	0.00142	0.00823	CrCrCtD
Alclometasone—CYP3A4—Mitoxantrone—hematologic cancer	0.00141	0.0107	CbGbCtD
Alclometasone—Flunisolide—Betamethasone—hematologic cancer	0.00141	0.00821	CrCrCtD
Alclometasone—Desonide—Betamethasone—hematologic cancer	0.00141	0.00821	CrCrCtD
Alclometasone—Flunisolide—Dexamethasone—hematologic cancer	0.00141	0.00821	CrCrCtD
Alclometasone—Prednisone—Betamethasone—hematologic cancer	0.00141	0.00821	CrCrCtD
Alclometasone—Diflorasone—Dexamethasone—hematologic cancer	0.00141	0.00821	CrCrCtD
Alclometasone—Prednisone—Dexamethasone—hematologic cancer	0.00141	0.00821	CrCrCtD
Alclometasone—Clobetasol propionate—Dexamethasone—hematologic cancer	0.00141	0.00821	CrCrCtD
Alclometasone—Clobetasol propionate—Betamethasone—hematologic cancer	0.00141	0.00821	CrCrCtD
Alclometasone—Desonide—Dexamethasone—hematologic cancer	0.00141	0.00821	CrCrCtD
Alclometasone—Diflorasone—Betamethasone—hematologic cancer	0.00141	0.00821	CrCrCtD
Alclometasone—Fluocortolone—Prednisolone—hematologic cancer	0.00139	0.00806	CrCrCtD
Alclometasone—Flunisolide—Triamcinolone—hematologic cancer	0.00138	0.00802	CrCrCtD
Alclometasone—Clobetasol propionate—Triamcinolone—hematologic cancer	0.00138	0.00802	CrCrCtD
Alclometasone—Prednisone—Triamcinolone—hematologic cancer	0.00138	0.00802	CrCrCtD
Alclometasone—Diflorasone—Triamcinolone—hematologic cancer	0.00138	0.00802	CrCrCtD
Alclometasone—Desonide—Triamcinolone—hematologic cancer	0.00138	0.00802	CrCrCtD
Alclometasone—Paramethasone—Dexamethasone—hematologic cancer	0.00138	0.008	CrCrCtD
Alclometasone—Paramethasone—Betamethasone—hematologic cancer	0.00138	0.008	CrCrCtD
Alclometasone—Fluocinolone Acetonide—Prednisolone—hematologic cancer	0.00135	0.00784	CrCrCtD
Alclometasone—Paramethasone—Triamcinolone—hematologic cancer	0.00135	0.00782	CrCrCtD
Alclometasone—Budesonide—Prednisone—hematologic cancer	0.00134	0.00782	CrCrCtD
Alclometasone—Desoximetasone—Dexamethasone—hematologic cancer	0.00134	0.00781	CrCrCtD
Alclometasone—Desoximetasone—Betamethasone—hematologic cancer	0.00134	0.00781	CrCrCtD
Alclometasone—Desoximetasone—Triamcinolone—hematologic cancer	0.00131	0.00763	CrCrCtD
Alclometasone—Budesonide—Prednisolone—hematologic cancer	0.00131	0.00763	CrCrCtD
Alclometasone—Loteprednol—Dexamethasone—hematologic cancer	0.00131	0.00763	CrCrCtD
Alclometasone—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.00131	0.00763	CrCrCtD
Alclometasone—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.00131	0.00763	CrCrCtD
Alclometasone—Loteprednol—Betamethasone—hematologic cancer	0.00131	0.00763	CrCrCtD
Alclometasone—Fluorometholone—Dexamethasone—hematologic cancer	0.00131	0.00763	CrCrCtD
Alclometasone—Fluorometholone—Betamethasone—hematologic cancer	0.00131	0.00763	CrCrCtD
Alclometasone—Triamcinolone—Dexamethasone—hematologic cancer	0.00131	0.00763	CrCrCtD
Alclometasone—Triamcinolone—Betamethasone—hematologic cancer	0.00131	0.00763	CrCrCtD
Alclometasone—Mometasone—Dexamethasone—hematologic cancer	0.00131	0.00763	CrCrCtD
Alclometasone—Mometasone—Betamethasone—hematologic cancer	0.00131	0.00763	CrCrCtD
Alclometasone—Desonide—Prednisone—hematologic cancer	0.00131	0.00761	CrCrCtD
Alclometasone—Clobetasol propionate—Prednisone—hematologic cancer	0.00131	0.00761	CrCrCtD
Alclometasone—Flunisolide—Prednisone—hematologic cancer	0.00131	0.00761	CrCrCtD
Alclometasone—Diflorasone—Prednisone—hematologic cancer	0.00131	0.00761	CrCrCtD
Alclometasone—Betamethasone—Dexamethasone—hematologic cancer	0.00128	0.00745	CrCrCtD
Alclometasone—Dexamethasone—Betamethasone—hematologic cancer	0.00128	0.00745	CrCrCtD
Alclometasone—Rimexolone—Betamethasone—hematologic cancer	0.00128	0.00745	CrCrCtD
Alclometasone—Rimexolone—Dexamethasone—hematologic cancer	0.00128	0.00745	CrCrCtD
Alclometasone—Mometasone—Triamcinolone—hematologic cancer	0.00128	0.00745	CrCrCtD
Alclometasone—Fluorometholone—Triamcinolone—hematologic cancer	0.00128	0.00745	CrCrCtD
Alclometasone—Loteprednol—Triamcinolone—hematologic cancer	0.00128	0.00745	CrCrCtD
Alclometasone—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.00128	0.00745	CrCrCtD
Alclometasone—Clobetasol propionate—Prednisolone—hematologic cancer	0.00128	0.00743	CrCrCtD
Alclometasone—Flunisolide—Prednisolone—hematologic cancer	0.00128	0.00743	CrCrCtD
Alclometasone—Prednisone—Prednisolone—hematologic cancer	0.00128	0.00743	CrCrCtD
Alclometasone—Diflorasone—Prednisolone—hematologic cancer	0.00128	0.00743	CrCrCtD
Alclometasone—Desonide—Prednisolone—hematologic cancer	0.00128	0.00743	CrCrCtD
Alclometasone—Paramethasone—Prednisone—hematologic cancer	0.00128	0.00742	CrCrCtD
Alclometasone—CYP3A4—Betamethasone—hematologic cancer	0.00126	0.00958	CbGbCtD
Alclometasone—Betamethasone—Triamcinolone—hematologic cancer	0.00125	0.00728	CrCrCtD
Alclometasone—Dexamethasone—Triamcinolone—hematologic cancer	0.00125	0.00728	CrCrCtD
Alclometasone—Rimexolone—Triamcinolone—hematologic cancer	0.00125	0.00728	CrCrCtD
Alclometasone—Paramethasone—Prednisolone—hematologic cancer	0.00125	0.00724	CrCrCtD
Alclometasone—Desoximetasone—Prednisone—hematologic cancer	0.00125	0.00724	CrCrCtD
Alclometasone—CYP3A4—Prednisolone—hematologic cancer	0.00124	0.00945	CbGbCtD
Alclometasone—Methylprednisolone—Betamethasone—hematologic cancer	0.00123	0.00713	CrCrCtD
Alclometasone—Methylprednisolone—Dexamethasone—hematologic cancer	0.00123	0.00713	CrCrCtD
Alclometasone—Loteprednol—Prednisone—hematologic cancer	0.00122	0.00707	CrCrCtD
Alclometasone—Fluorometholone—Prednisone—hematologic cancer	0.00122	0.00707	CrCrCtD
Alclometasone—Triamcinolone—Prednisone—hematologic cancer	0.00122	0.00707	CrCrCtD
Alclometasone—Mometasone—Prednisone—hematologic cancer	0.00122	0.00707	CrCrCtD
Alclometasone—Fluprednidene Acetate—Prednisone—hematologic cancer	0.00122	0.00707	CrCrCtD
Alclometasone—Desoximetasone—Prednisolone—hematologic cancer	0.00122	0.00707	CrCrCtD
Alclometasone—Prednisolone—Dexamethasone—hematologic cancer	0.0012	0.00698	CrCrCtD
Alclometasone—Prednisolone—Betamethasone—hematologic cancer	0.0012	0.00698	CrCrCtD
Alclometasone—Methylprednisolone—Triamcinolone—hematologic cancer	0.0012	0.00696	CrCrCtD
Alclometasone—Dexamethasone—Prednisone—hematologic cancer	0.00119	0.00691	CrCrCtD
Alclometasone—Betamethasone—Prednisone—hematologic cancer	0.00119	0.00691	CrCrCtD
Alclometasone—Rimexolone—Prednisone—hematologic cancer	0.00119	0.00691	CrCrCtD
Alclometasone—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.00119	0.0069	CrCrCtD
Alclometasone—Fluorometholone—Prednisolone—hematologic cancer	0.00119	0.0069	CrCrCtD
Alclometasone—Loteprednol—Prednisolone—hematologic cancer	0.00119	0.0069	CrCrCtD
Alclometasone—Mometasone—Prednisolone—hematologic cancer	0.00119	0.0069	CrCrCtD
Alclometasone—Triamcinolone—Prednisolone—hematologic cancer	0.00119	0.0069	CrCrCtD
Alclometasone—CYP3A4—Prednisone—hematologic cancer	0.00117	0.00892	CbGbCtD
Alclometasone—Prednisolone—Triamcinolone—hematologic cancer	0.00117	0.00682	CrCrCtD
Alclometasone—Betamethasone—Prednisolone—hematologic cancer	0.00116	0.00674	CrCrCtD
Alclometasone—Rimexolone—Prednisolone—hematologic cancer	0.00116	0.00674	CrCrCtD
Alclometasone—Dexamethasone—Prednisolone—hematologic cancer	0.00116	0.00674	CrCrCtD
Alclometasone—Hydrocortisone—Betamethasone—hematologic cancer	0.00115	0.0067	CrCrCtD
Alclometasone—Hydrocortisone—Dexamethasone—hematologic cancer	0.00115	0.0067	CrCrCtD
Alclometasone—Methylprednisolone—Prednisone—hematologic cancer	0.00114	0.00661	CrCrCtD
Alclometasone—Hydrocortisone—Triamcinolone—hematologic cancer	0.00113	0.00654	CrCrCtD
Alclometasone—Prednisolone—Prednisone—hematologic cancer	0.00111	0.00647	CrCrCtD
Alclometasone—CYP3A4—Irinotecan—hematologic cancer	0.00111	0.00846	CbGbCtD
Alclometasone—Methylprednisolone—Prednisolone—hematologic cancer	0.00111	0.00645	CrCrCtD
Alclometasone—Hydrocortisone—Prednisone—hematologic cancer	0.00107	0.00621	CrCrCtD
Alclometasone—Hydrocortisone—Prednisolone—hematologic cancer	0.00104	0.00606	CrCrCtD
Alclometasone—CYP3A4—Vinblastine—hematologic cancer	0.000989	0.00752	CbGbCtD
Alclometasone—CYP3A4—Vincristine—hematologic cancer	0.000972	0.00739	CbGbCtD
Alclometasone—CYP3A4—Etoposide—hematologic cancer	0.000891	0.00678	CbGbCtD
Alclometasone—CYP3A4—Dexamethasone—hematologic cancer	0.000732	0.00557	CbGbCtD
Alclometasone—CYP3A4—Doxorubicin—hematologic cancer	0.000608	0.00462	CbGbCtD
Alclometasone—Acneiform eruption—Triamcinolone—hematologic cancer	0.000374	0.0107	CcSEcCtD
Alclometasone—Leukoderma—Thiotepa—hematologic cancer	0.000341	0.00974	CcSEcCtD
Alclometasone—Acneiform eruption—Betamethasone—hematologic cancer	0.00034	0.00969	CcSEcCtD
Alclometasone—Acneiform eruption—Dexamethasone—hematologic cancer	0.00034	0.00969	CcSEcCtD
Alclometasone—Skin striae—Prednisolone—hematologic cancer	0.000323	0.00923	CcSEcCtD
Alclometasone—Miliaria—Triamcinolone—hematologic cancer	0.000322	0.00918	CcSEcCtD
Alclometasone—Secondary infection—Triamcinolone—hematologic cancer	0.000322	0.00918	CcSEcCtD
Alclometasone—Leukoderma—Alitretinoin—hematologic cancer	0.000314	0.00897	CcSEcCtD
Alclometasone—Skin atrophy—Triamcinolone—hematologic cancer	0.000313	0.00894	CcSEcCtD
Alclometasone—Folliculitis—Nilotinib—hematologic cancer	0.00031	0.00886	CcSEcCtD
Alclometasone—Folliculitis—Imatinib—hematologic cancer	0.000309	0.00881	CcSEcCtD
Alclometasone—Skin striae—Triamcinolone—hematologic cancer	0.000297	0.00849	CcSEcCtD
Alclometasone—Acneiform eruption—Prednisone—hematologic cancer	0.000296	0.00844	CcSEcCtD
Alclometasone—Secondary infection—Dexamethasone—hematologic cancer	0.000292	0.00833	CcSEcCtD
Alclometasone—Miliaria—Dexamethasone—hematologic cancer	0.000292	0.00833	CcSEcCtD
Alclometasone—Miliaria—Betamethasone—hematologic cancer	0.000292	0.00833	CcSEcCtD
Alclometasone—Secondary infection—Betamethasone—hematologic cancer	0.000292	0.00833	CcSEcCtD
Alclometasone—Skin atrophy—Betamethasone—hematologic cancer	0.000284	0.00811	CcSEcCtD
Alclometasone—Skin atrophy—Dexamethasone—hematologic cancer	0.000284	0.00811	CcSEcCtD
Alclometasone—Dermatitis acneiform—Triamcinolone—hematologic cancer	0.000277	0.0079	CcSEcCtD
Alclometasone—Allergic contact dermatitis—Triamcinolone—hematologic cancer	0.000271	0.00772	CcSEcCtD
Alclometasone—Skin striae—Dexamethasone—hematologic cancer	0.00027	0.0077	CcSEcCtD
Alclometasone—Skin striae—Betamethasone—hematologic cancer	0.00027	0.0077	CcSEcCtD
Alclometasone—Dermatitis contact—Daunorubicin—hematologic cancer	0.000254	0.00724	CcSEcCtD
Alclometasone—Dermatitis acneiform—Betamethasone—hematologic cancer	0.000251	0.00717	CcSEcCtD
Alclometasone—Dermatitis acneiform—Dexamethasone—hematologic cancer	0.000251	0.00717	CcSEcCtD
Alclometasone—Skin atrophy—Prednisone—hematologic cancer	0.000247	0.00706	CcSEcCtD
Alclometasone—Allergic contact dermatitis—Dexamethasone—hematologic cancer	0.000246	0.00701	CcSEcCtD
Alclometasone—Allergic contact dermatitis—Betamethasone—hematologic cancer	0.000246	0.00701	CcSEcCtD
Alclometasone—Leukoderma—Prednisolone—hematologic cancer	0.000242	0.0069	CcSEcCtD
Alclometasone—Skin striae—Prednisone—hematologic cancer	0.000235	0.00671	CcSEcCtD
Alclometasone—Leukoderma—Triamcinolone—hematologic cancer	0.000222	0.00635	CcSEcCtD
Alclometasone—Dermatitis acneiform—Prednisone—hematologic cancer	0.000219	0.00624	CcSEcCtD
Alclometasone—Folliculitis—Alitretinoin—hematologic cancer	0.000212	0.00607	CcSEcCtD
Alclometasone—Dermatitis contact—Bexarotene—hematologic cancer	0.000209	0.00596	CcSEcCtD
Alclometasone—Leukoderma—Betamethasone—hematologic cancer	0.000202	0.00576	CcSEcCtD
Alclometasone—Leukoderma—Dexamethasone—hematologic cancer	0.000202	0.00576	CcSEcCtD
Alclometasone—Secondary infection—Epirubicin—hematologic cancer	0.000199	0.00568	CcSEcCtD
Alclometasone—Secondary infection—Doxorubicin—hematologic cancer	0.000184	0.00525	CcSEcCtD
Alclometasone—Leukoderma—Prednisone—hematologic cancer	0.000176	0.00502	CcSEcCtD
Alclometasone—Infection—Ruxolitinib—hematologic cancer	0.000159	0.00453	CcSEcCtD
Alclometasone—Folliculitis—Triamcinolone—hematologic cancer	0.00015	0.00429	CcSEcCtD
Alclometasone—Leukoderma—Methotrexate—hematologic cancer	0.000147	0.00419	CcSEcCtD
Alclometasone—Dermatitis contact—Thiotepa—hematologic cancer	0.000143	0.00409	CcSEcCtD
Alclometasone—Leukoderma—Epirubicin—hematologic cancer	0.000137	0.00392	CcSEcCtD
Alclometasone—Folliculitis—Dexamethasone—hematologic cancer	0.000136	0.0039	CcSEcCtD
Alclometasone—Folliculitis—Betamethasone—hematologic cancer	0.000136	0.0039	CcSEcCtD
Alclometasone—Infection—Vorinostat—hematologic cancer	0.000134	0.00383	CcSEcCtD
Alclometasone—Dermatitis contact—Alitretinoin—hematologic cancer	0.000132	0.00377	CcSEcCtD
Alclometasone—SERPINA6—hematopoietic system—hematologic cancer	0.00013	0.184	CbGeAlD
Alclometasone—Leukoderma—Doxorubicin—hematologic cancer	0.000127	0.00363	CcSEcCtD
Alclometasone—Infection—Lomustine—hematologic cancer	0.00012	0.00343	CcSEcCtD
Alclometasone—Erythema—Methoxsalen—hematologic cancer	0.000117	0.00334	CcSEcCtD
Alclometasone—Infection—Mechlorethamine—hematologic cancer	0.000115	0.00329	CcSEcCtD
Alclometasone—Pruritus—Ruxolitinib—hematologic cancer	0.000113	0.00323	CcSEcCtD
Alclometasone—Erythema—Daunorubicin—hematologic cancer	0.000112	0.0032	CcSEcCtD
Alclometasone—Erythema—Clofarabine—hematologic cancer	0.000112	0.0032	CcSEcCtD
Alclometasone—Folliculitis—Methotrexate—hematologic cancer	9.93e-05	0.00284	CcSEcCtD
Alclometasone—Infection—Nelarabine—hematologic cancer	9.72e-05	0.00277	CcSEcCtD
Alclometasone—Erythema—Busulfan—hematologic cancer	9.71e-05	0.00277	CcSEcCtD
Alclometasone—Pruritus—Vorinostat—hematologic cancer	9.55e-05	0.00273	CcSEcCtD
Alclometasone—Infection—Methoxsalen—hematologic cancer	9.49e-05	0.00271	CcSEcCtD
Alclometasone—Dermatitis contact—Triamcinolone—hematologic cancer	9.34e-05	0.00267	CcSEcCtD
Alclometasone—Folliculitis—Epirubicin—hematologic cancer	9.3e-05	0.00265	CcSEcCtD
Alclometasone—Erythema—Bexarotene—hematologic cancer	9.23e-05	0.00264	CcSEcCtD
Alclometasone—Erythema—Dasatinib—hematologic cancer	9.23e-05	0.00264	CcSEcCtD
Alclometasone—Infection—Daunorubicin—hematologic cancer	9.1e-05	0.0026	CcSEcCtD
Alclometasone—Infection—Clofarabine—hematologic cancer	9.1e-05	0.0026	CcSEcCtD
Alclometasone—Infection—Pentostatin—hematologic cancer	9.05e-05	0.00258	CcSEcCtD
Alclometasone—Infection—Anagrelide—hematologic cancer	9.05e-05	0.00258	CcSEcCtD
Alclometasone—Infection—Idarubicin—hematologic cancer	8.73e-05	0.00249	CcSEcCtD
Alclometasone—Folliculitis—Doxorubicin—hematologic cancer	8.6e-05	0.00246	CcSEcCtD
Alclometasone—SERPINA6—blood—hematologic cancer	8.6e-05	0.122	CbGeAlD
Alclometasone—Erythema—Nilotinib—hematologic cancer	8.53e-05	0.00244	CcSEcCtD
Alclometasone—Infection—Teniposide—hematologic cancer	8.49e-05	0.00242	CcSEcCtD
Alclometasone—Erythema—Imatinib—hematologic cancer	8.48e-05	0.00242	CcSEcCtD
Alclometasone—Dermatitis contact—Betamethasone—hematologic cancer	8.48e-05	0.00242	CcSEcCtD
Alclometasone—Dermatitis contact—Dexamethasone—hematologic cancer	8.48e-05	0.00242	CcSEcCtD
Alclometasone—Erythema—Cladribine—hematologic cancer	8.33e-05	0.00238	CcSEcCtD
Alclometasone—SERPINA6—bone marrow—hematologic cancer	8.32e-05	0.118	CbGeAlD
Alclometasone—Pruritus—Mechlorethamine—hematologic cancer	8.2e-05	0.00234	CcSEcCtD
Alclometasone—Infection—Busulfan—hematologic cancer	7.87e-05	0.00225	CcSEcCtD
Alclometasone—Infection—Procarbazine—hematologic cancer	7.64e-05	0.00218	CcSEcCtD
Alclometasone—SERPINA6—lung—hematologic cancer	7.54e-05	0.107	CbGeAlD
Alclometasone—Infection—Dasatinib—hematologic cancer	7.49e-05	0.00214	CcSEcCtD
Alclometasone—Infection—Bexarotene—hematologic cancer	7.49e-05	0.00214	CcSEcCtD
Alclometasone—Infection—Fludarabine—hematologic cancer	7.47e-05	0.00213	CcSEcCtD
Alclometasone—Erythema—Lenalidomide—hematologic cancer	7.39e-05	0.00211	CcSEcCtD
Alclometasone—Rash—Mechlorethamine—hematologic cancer	7.31e-05	0.00209	CcSEcCtD
Alclometasone—Dermatitis—Mechlorethamine—hematologic cancer	7.31e-05	0.00209	CcSEcCtD
Alclometasone—Erythema—Hydroxyurea—hematologic cancer	7.29e-05	0.00208	CcSEcCtD
Alclometasone—Infection—Chlorambucil—hematologic cancer	7.07e-05	0.00202	CcSEcCtD
Alclometasone—Infection—Nilotinib—hematologic cancer	6.92e-05	0.00197	CcSEcCtD
Alclometasone—Infection—Imatinib—hematologic cancer	6.88e-05	0.00196	CcSEcCtD
Alclometasone—Erythema—Bortezomib—hematologic cancer	6.8e-05	0.00194	CcSEcCtD
Alclometasone—Pruritus—Methoxsalen—hematologic cancer	6.76e-05	0.00193	CcSEcCtD
Alclometasone—Infection—Cladribine—hematologic cancer	6.76e-05	0.00193	CcSEcCtD
Alclometasone—Erythema—Bleomycin—hematologic cancer	6.75e-05	0.00193	CcSEcCtD
Alclometasone—Erythema—Vinorelbine—hematologic cancer	6.64e-05	0.0019	CcSEcCtD
Alclometasone—Pruritus—Daunorubicin—hematologic cancer	6.48e-05	0.00185	CcSEcCtD
Alclometasone—Pruritus—Clofarabine—hematologic cancer	6.48e-05	0.00185	CcSEcCtD
Alclometasone—Pruritus—Anagrelide—hematologic cancer	6.45e-05	0.00184	CcSEcCtD
Alclometasone—Pruritus—Pentostatin—hematologic cancer	6.45e-05	0.00184	CcSEcCtD
Alclometasone—Erythema—Thiotepa—hematologic cancer	6.34e-05	0.00181	CcSEcCtD
Alclometasone—Infection—Melphalan—hematologic cancer	6.16e-05	0.00176	CcSEcCtD
Alclometasone—Pruritus—Teniposide—hematologic cancer	6.05e-05	0.00173	CcSEcCtD
Alclometasone—Rash—Methoxsalen—hematologic cancer	6.03e-05	0.00172	CcSEcCtD
Alclometasone—Dermatitis—Methoxsalen—hematologic cancer	6.02e-05	0.00172	CcSEcCtD
Alclometasone—Infection—Lenalidomide—hematologic cancer	5.99e-05	0.00171	CcSEcCtD
Alclometasone—Infection—Hydroxyurea—hematologic cancer	5.91e-05	0.00169	CcSEcCtD
Alclometasone—Erythema—Carmustine—hematologic cancer	5.89e-05	0.00168	CcSEcCtD
Alclometasone—Rash—Mercaptopurine—hematologic cancer	5.85e-05	0.00167	CcSEcCtD
Alclometasone—Dermatitis—Mercaptopurine—hematologic cancer	5.85e-05	0.00167	CcSEcCtD
Alclometasone—Erythema—Alitretinoin—hematologic cancer	5.84e-05	0.00167	CcSEcCtD
Alclometasone—Dermatitis contact—Epirubicin—hematologic cancer	5.77e-05	0.00165	CcSEcCtD
Alclometasone—Rash—Clofarabine—hematologic cancer	5.77e-05	0.00165	CcSEcCtD
Alclometasone—Rash—Daunorubicin—hematologic cancer	5.77e-05	0.00165	CcSEcCtD
Alclometasone—Erythema—Ifosfamide—hematologic cancer	5.77e-05	0.00165	CcSEcCtD
Alclometasone—Dermatitis—Clofarabine—hematologic cancer	5.77e-05	0.00165	CcSEcCtD
Alclometasone—Dermatitis—Daunorubicin—hematologic cancer	5.77e-05	0.00165	CcSEcCtD
Alclometasone—Rash—Anagrelide—hematologic cancer	5.75e-05	0.00164	CcSEcCtD
Alclometasone—Rash—Pentostatin—hematologic cancer	5.75e-05	0.00164	CcSEcCtD
Alclometasone—Dermatitis—Pentostatin—hematologic cancer	5.74e-05	0.00164	CcSEcCtD
Alclometasone—Dermatitis—Anagrelide—hematologic cancer	5.74e-05	0.00164	CcSEcCtD
Alclometasone—NR3C1—hematopoietic system—hematologic cancer	5.68e-05	0.0804	CbGeAlD
Alclometasone—Pruritus—Busulfan—hematologic cancer	5.61e-05	0.0016	CcSEcCtD
Alclometasone—Rash—Idarubicin—hematologic cancer	5.54e-05	0.00158	CcSEcCtD
Alclometasone—Dermatitis—Idarubicin—hematologic cancer	5.54e-05	0.00158	CcSEcCtD
Alclometasone—Infection—Bortezomib—hematologic cancer	5.52e-05	0.00157	CcSEcCtD
Alclometasone—Erythema—Mitoxantrone—hematologic cancer	5.48e-05	0.00156	CcSEcCtD
Alclometasone—Infection—Bleomycin—hematologic cancer	5.47e-05	0.00156	CcSEcCtD
Alclometasone—Pruritus—Procarbazine—hematologic cancer	5.44e-05	0.00155	CcSEcCtD
Alclometasone—Rash—Teniposide—hematologic cancer	5.39e-05	0.00154	CcSEcCtD
Alclometasone—Dermatitis—Teniposide—hematologic cancer	5.39e-05	0.00154	CcSEcCtD
Alclometasone—Infection—Vinorelbine—hematologic cancer	5.39e-05	0.00154	CcSEcCtD
Alclometasone—Dermatitis contact—Doxorubicin—hematologic cancer	5.34e-05	0.00153	CcSEcCtD
Alclometasone—Erythema—Gemcitabine—hematologic cancer	5.34e-05	0.00152	CcSEcCtD
Alclometasone—Pruritus—Bexarotene—hematologic cancer	5.33e-05	0.00152	CcSEcCtD
Alclometasone—Pruritus—Dasatinib—hematologic cancer	5.33e-05	0.00152	CcSEcCtD
Alclometasone—Pruritus—Fludarabine—hematologic cancer	5.32e-05	0.00152	CcSEcCtD
Alclometasone—Prednicarbate—NR3C1—hematologic cancer	5.24e-05	0.0508	CrCbGaD
Alclometasone—Clocortolone—NR3C1—hematologic cancer	5.24e-05	0.0508	CrCbGaD
Alclometasone—Infection—Thiotepa—hematologic cancer	5.14e-05	0.00147	CcSEcCtD
Alclometasone—Pruritus—Chlorambucil—hematologic cancer	5.04e-05	0.00144	CcSEcCtD
Alclometasone—Rash—Busulfan—hematologic cancer	5e-05	0.00143	CcSEcCtD
Alclometasone—Dermatitis—Busulfan—hematologic cancer	4.99e-05	0.00142	CcSEcCtD
Alclometasone—Infection—Thalidomide—hematologic cancer	4.97e-05	0.00142	CcSEcCtD
Alclometasone—Erythema—Cisplatin—hematologic cancer	4.97e-05	0.00142	CcSEcCtD
Alclometasone—Desonide—NR3C1—hematologic cancer	4.96e-05	0.0481	CrCbGaD
Alclometasone—Diflorasone—NR3C1—hematologic cancer	4.96e-05	0.0481	CrCbGaD
Alclometasone—Pruritus—Nilotinib—hematologic cancer	4.93e-05	0.00141	CcSEcCtD
Alclometasone—Pruritus—Imatinib—hematologic cancer	4.9e-05	0.0014	CcSEcCtD
Alclometasone—Rash—Procarbazine—hematologic cancer	4.85e-05	0.00138	CcSEcCtD
Alclometasone—Dermatitis—Procarbazine—hematologic cancer	4.84e-05	0.00138	CcSEcCtD
Alclometasone—Desoximetasone—NR3C1—hematologic cancer	4.84e-05	0.0469	CrCbGaD
Alclometasone—Pruritus—Cladribine—hematologic cancer	4.81e-05	0.00137	CcSEcCtD
Alclometasone—Loteprednol—NR3C1—hematologic cancer	4.78e-05	0.0463	CrCbGaD
Alclometasone—Infection—Carmustine—hematologic cancer	4.78e-05	0.00136	CcSEcCtD
Alclometasone—Rash—Bexarotene—hematologic cancer	4.75e-05	0.00136	CcSEcCtD
Alclometasone—Rash—Dasatinib—hematologic cancer	4.75e-05	0.00136	CcSEcCtD
Alclometasone—Dermatitis—Dasatinib—hematologic cancer	4.75e-05	0.00136	CcSEcCtD
Alclometasone—Dermatitis—Bexarotene—hematologic cancer	4.75e-05	0.00136	CcSEcCtD
Alclometasone—Rash—Fludarabine—hematologic cancer	4.74e-05	0.00135	CcSEcCtD
Alclometasone—Dermatitis—Fludarabine—hematologic cancer	4.73e-05	0.00135	CcSEcCtD
Alclometasone—Infection—Alitretinoin—hematologic cancer	4.73e-05	0.00135	CcSEcCtD
Alclometasone—Infection—Ifosfamide—hematologic cancer	4.68e-05	0.00134	CcSEcCtD
Alclometasone—Infection—Vincristine—hematologic cancer	4.56e-05	0.0013	CcSEcCtD
Alclometasone—Erythema—Prednisolone—hematologic cancer	4.49e-05	0.00128	CcSEcCtD
Alclometasone—Infection—Mitoxantrone—hematologic cancer	4.44e-05	0.00127	CcSEcCtD
Alclometasone—Infection—Irinotecan—hematologic cancer	4.44e-05	0.00127	CcSEcCtD
Alclometasone—Pruritus—Melphalan—hematologic cancer	4.39e-05	0.00125	CcSEcCtD
Alclometasone—Rash—Nilotinib—hematologic cancer	4.39e-05	0.00125	CcSEcCtD
Alclometasone—Dermatitis—Nilotinib—hematologic cancer	4.39e-05	0.00125	CcSEcCtD
Alclometasone—Rash—Imatinib—hematologic cancer	4.36e-05	0.00125	CcSEcCtD
Alclometasone—Dermatitis—Imatinib—hematologic cancer	4.36e-05	0.00124	CcSEcCtD
Alclometasone—Infection—Gemcitabine—hematologic cancer	4.33e-05	0.00124	CcSEcCtD
Alclometasone—NR3C1—gonad—hematologic cancer	4.32e-05	0.0612	CbGeAlD
Alclometasone—CYP3A4—hematopoietic system—hematologic cancer	4.3e-05	0.0608	CbGeAlD
Alclometasone—Rash—Cladribine—hematologic cancer	4.29e-05	0.00122	CcSEcCtD
Alclometasone—Dermatitis—Cladribine—hematologic cancer	4.28e-05	0.00122	CcSEcCtD
Alclometasone—Pruritus—Lenalidomide—hematologic cancer	4.27e-05	0.00122	CcSEcCtD
Alclometasone—Flurandrenolide—NR3C1—hematologic cancer	4.23e-05	0.0411	CrCbGaD
Alclometasone—Flumethasone Pivalate—NR3C1—hematologic cancer	4.16e-05	0.0404	CrCbGaD
Alclometasone—Erythema—Triamcinolone—hematologic cancer	4.13e-05	0.00118	CcSEcCtD
Alclometasone—Halobetasol Propionate—NR3C1—hematologic cancer	4.09e-05	0.0397	CrCbGaD
Alclometasone—Infection—Cisplatin—hematologic cancer	4.03e-05	0.00115	CcSEcCtD
Alclometasone—Pruritus—Bortezomib—hematologic cancer	3.93e-05	0.00112	CcSEcCtD
Alclometasone—Rash—Melphalan—hematologic cancer	3.91e-05	0.00112	CcSEcCtD
Alclometasone—Dermatitis—Melphalan—hematologic cancer	3.91e-05	0.00112	CcSEcCtD
Alclometasone—Pruritus—Bleomycin—hematologic cancer	3.9e-05	0.00111	CcSEcCtD
Alclometasone—Pruritus—Vinorelbine—hematologic cancer	3.84e-05	0.00109	CcSEcCtD
Alclometasone—NR3C1—Adipogenesis—NCOR2—hematologic cancer	3.83e-05	0.00331	CbGpPWpGaD
Alclometasone—Budesonide—NR3C1—hematologic cancer	3.81e-05	0.0369	CrCbGaD
Alclometasone—Rash—Lenalidomide—hematologic cancer	3.8e-05	0.00109	CcSEcCtD
Alclometasone—Dermatitis—Lenalidomide—hematologic cancer	3.8e-05	0.00109	CcSEcCtD
Alclometasone—NR3C1—blood—hematologic cancer	3.77e-05	0.0533	CbGeAlD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—hematologic cancer	3.76e-05	0.00325	CbGpPWpGaD
Alclometasone—Rash—Hydroxyurea—hematologic cancer	3.75e-05	0.00107	CcSEcCtD
Alclometasone—Erythema—Betamethasone—hematologic cancer	3.75e-05	0.00107	CcSEcCtD
Alclometasone—Erythema—Dexamethasone—hematologic cancer	3.75e-05	0.00107	CcSEcCtD
Alclometasone—Dermatitis—Hydroxyurea—hematologic cancer	3.75e-05	0.00107	CcSEcCtD
Alclometasone—NR3C1—Nuclear Receptors—ESR1—hematologic cancer	3.75e-05	0.00324	CbGpPWpGaD
Alclometasone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—hematologic cancer	3.75e-05	0.00324	CbGpPWpGaD
Alclometasone—CYP3A4—Estrogen metabolism—NQO1—hematologic cancer	3.75e-05	0.00324	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—GATA3—hematologic cancer	3.72e-05	0.00322	CbGpPWpGaD
Alclometasone—Infection—Etoposide—hematologic cancer	3.69e-05	0.00105	CcSEcCtD
Alclometasone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	3.67e-05	0.00317	CbGpPWpGaD
Alclometasone—Pruritus—Thiotepa—hematologic cancer	3.66e-05	0.00105	CcSEcCtD
Alclometasone—NR3C1—bone marrow—hematologic cancer	3.64e-05	0.0516	CbGeAlD
Alclometasone—Mometasone—NR3C1—hematologic cancer	3.62e-05	0.0351	CrCbGaD
Alclometasone—Rimexolone—NR3C1—hematologic cancer	3.58e-05	0.0347	CrCbGaD
Alclometasone—NR3C1—Regulation of Androgen receptor activity—FOXO1—hematologic cancer	3.56e-05	0.00308	CbGpPWpGaD
Alclometasone—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—hematologic cancer	3.55e-05	0.00307	CbGpPWpGaD
Alclometasone—NR3C1—Circadian Clock—NCOR1—hematologic cancer	3.55e-05	0.00307	CbGpPWpGaD
Alclometasone—Pruritus—Thalidomide—hematologic cancer	3.54e-05	0.00101	CcSEcCtD
Alclometasone—NR3C1—Endoderm Differentiation—STAT1—hematologic cancer	3.54e-05	0.00306	CbGpPWpGaD
Alclometasone—Rash—Bortezomib—hematologic cancer	3.5e-05	0.000999	CcSEcCtD
Alclometasone—Dermatitis—Bortezomib—hematologic cancer	3.5e-05	0.000998	CcSEcCtD
Alclometasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	3.49e-05	0.00302	CbGpPWpGaD
Alclometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—hematologic cancer	3.49e-05	0.00302	CbGpPWpGaD
Alclometasone—Rash—Bleomycin—hematologic cancer	3.47e-05	0.000992	CcSEcCtD
Alclometasone—Dermatitis—Bleomycin—hematologic cancer	3.47e-05	0.000991	CcSEcCtD
Alclometasone—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	3.45e-05	0.00298	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—hematologic cancer	3.44e-05	0.00297	CbGpPWpGaD
Alclometasone—Rash—Vinorelbine—hematologic cancer	3.42e-05	0.000976	CcSEcCtD
Alclometasone—Dermatitis—Vinorelbine—hematologic cancer	3.41e-05	0.000975	CcSEcCtD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—hematologic cancer	3.4e-05	0.00294	CbGpPWpGaD
Alclometasone—Beclomethasone—NR3C1—hematologic cancer	3.38e-05	0.0327	CrCbGaD
Alclometasone—Pruritus—Alitretinoin—hematologic cancer	3.37e-05	0.000962	CcSEcCtD
Alclometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—hematologic cancer	3.35e-05	0.0029	CbGpPWpGaD
Alclometasone—Infection—Triamcinolone—hematologic cancer	3.35e-05	0.000957	CcSEcCtD
Alclometasone—Pruritus—Ifosfamide—hematologic cancer	3.33e-05	0.000951	CcSEcCtD
Alclometasone—NR3C1—lung—hematologic cancer	3.3e-05	0.0467	CbGeAlD
Alclometasone—Fluocinolone Acetonide—NR3C1—hematologic cancer	3.28e-05	0.0318	CrCbGaD
Alclometasone—Erythema—Prednisone—hematologic cancer	3.27e-05	0.000932	CcSEcCtD
Alclometasone—Rash—Thiotepa—hematologic cancer	3.26e-05	0.000932	CcSEcCtD
Alclometasone—Dermatitis—Thiotepa—hematologic cancer	3.26e-05	0.000931	CcSEcCtD
Alclometasone—Flunisolide—NR3C1—hematologic cancer	3.19e-05	0.031	CrCbGaD
Alclometasone—Clobetasol propionate—NR3C1—hematologic cancer	3.19e-05	0.031	CrCbGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—HSP90AA1—hematologic cancer	3.16e-05	0.00273	CbGpPWpGaD
Alclometasone—Rash—Thalidomide—hematologic cancer	3.16e-05	0.000901	CcSEcCtD
Alclometasone—Paramethasone—NR3C1—hematologic cancer	3.15e-05	0.0306	CrCbGaD
Alclometasone—Dermatitis—Thalidomide—hematologic cancer	3.15e-05	0.000901	CcSEcCtD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—RUNX3—hematologic cancer	3.12e-05	0.0027	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—STAT5B—hematologic cancer	3.12e-05	0.00269	CbGpPWpGaD
Alclometasone—NR3C1—testis—hematologic cancer	3.12e-05	0.0441	CbGeAlD
Alclometasone—Ciclesonide—NR3C1—hematologic cancer	3.1e-05	0.0301	CrCbGaD
Alclometasone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—hematologic cancer	3.1e-05	0.00268	CbGpPWpGaD
Alclometasone—Pruritus—Gemcitabine—hematologic cancer	3.08e-05	0.00088	CcSEcCtD
Alclometasone—Fluorometholone—NR3C1—hematologic cancer	3.08e-05	0.0299	CrCbGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—STAT1—hematologic cancer	3.05e-05	0.00264	CbGpPWpGaD
Alclometasone—Infection—Betamethasone—hematologic cancer	3.04e-05	0.000868	CcSEcCtD
Alclometasone—Infection—Dexamethasone—hematologic cancer	3.04e-05	0.000868	CcSEcCtD
Alclometasone—Rash—Carmustine—hematologic cancer	3.03e-05	0.000866	CcSEcCtD
Alclometasone—Dermatitis—Carmustine—hematologic cancer	3.03e-05	0.000865	CcSEcCtD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—HDAC9—hematologic cancer	3.02e-05	0.00261	CbGpPWpGaD
Alclometasone—Rash—Alitretinoin—hematologic cancer	3e-05	0.000858	CcSEcCtD
Alclometasone—Dermatitis—Alitretinoin—hematologic cancer	3e-05	0.000857	CcSEcCtD
Alclometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—hematologic cancer	3e-05	0.00259	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—FOXM1—hematologic cancer	2.99e-05	0.00259	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—hematologic cancer	2.98e-05	0.00257	CbGpPWpGaD
Alclometasone—Methylprednisolone—NR3C1—hematologic cancer	2.98e-05	0.0289	CrCbGaD
Alclometasone—Rash—Ifosfamide—hematologic cancer	2.97e-05	0.000848	CcSEcCtD
Alclometasone—Dermatitis—Ifosfamide—hematologic cancer	2.97e-05	0.000847	CcSEcCtD
Alclometasone—NR3C1—Nuclear Receptor transcription pathway—ESR1—hematologic cancer	2.96e-05	0.00256	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of Androgen receptor activity—MAPK14—hematologic cancer	2.93e-05	0.00253	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—IL10—hematologic cancer	2.93e-05	0.00253	CbGpPWpGaD
Alclometasone—Rash—Vincristine—hematologic cancer	2.89e-05	0.000826	CcSEcCtD
Alclometasone—NR3C1—AP-1 transcription factor network—CSF2—hematologic cancer	2.89e-05	0.0025	CbGpPWpGaD
Alclometasone—Dermatitis—Vincristine—hematologic cancer	2.89e-05	0.000826	CcSEcCtD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—MYB—hematologic cancer	2.88e-05	0.00249	CbGpPWpGaD
Alclometasone—CYP3A4—Estrogen metabolism—GSTM1—hematologic cancer	2.87e-05	0.00248	CbGpPWpGaD
Alclometasone—CYP3A4—blood—hematologic cancer	2.85e-05	0.0403	CbGeAlD
Alclometasone—NR3C1—AP-1 transcription factor network—IL4—hematologic cancer	2.85e-05	0.00246	CbGpPWpGaD
Alclometasone—Rash—Mitoxantrone—hematologic cancer	2.82e-05	0.000805	CcSEcCtD
Alclometasone—Rash—Irinotecan—hematologic cancer	2.82e-05	0.000805	CcSEcCtD
Alclometasone—Dermatitis—Irinotecan—hematologic cancer	2.82e-05	0.000804	CcSEcCtD
Alclometasone—Dermatitis—Mitoxantrone—hematologic cancer	2.82e-05	0.000804	CcSEcCtD
Alclometasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—hematologic cancer	2.81e-05	0.00243	CbGpPWpGaD
Alclometasone—Rash—Gemcitabine—hematologic cancer	2.75e-05	0.000784	CcSEcCtD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—hematologic cancer	2.75e-05	0.00237	CbGpPWpGaD
Alclometasone—Dermatitis—Gemcitabine—hematologic cancer	2.74e-05	0.000783	CcSEcCtD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—STAT5A—hematologic cancer	2.74e-05	0.00237	CbGpPWpGaD
Alclometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hematologic cancer	2.73e-05	0.00236	CbGpPWpGaD
Alclometasone—Erythema—Methotrexate—hematologic cancer	2.73e-05	0.000779	CcSEcCtD
Alclometasone—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	2.69e-05	0.00233	CbGpPWpGaD
Alclometasone—Infection—Prednisone—hematologic cancer	2.65e-05	0.000756	CcSEcCtD
Alclometasone—Pruritus—Etoposide—hematologic cancer	2.63e-05	0.000751	CcSEcCtD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hematologic cancer	2.6e-05	0.00225	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—hematologic cancer	2.6e-05	0.00225	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—HLA-A—hematologic cancer	2.58e-05	0.00223	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—GATA3—hematologic cancer	2.57e-05	0.00222	CbGpPWpGaD
Alclometasone—Rash—Cisplatin—hematologic cancer	2.56e-05	0.000731	CcSEcCtD
Alclometasone—Dermatitis—Cisplatin—hematologic cancer	2.56e-05	0.00073	CcSEcCtD
Alclometasone—Erythema—Epirubicin—hematologic cancer	2.55e-05	0.000729	CcSEcCtD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—CSF2—hematologic cancer	2.55e-05	0.0022	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—hematologic cancer	2.54e-05	0.00219	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of Androgen receptor activity—CREBBP—hematologic cancer	2.52e-05	0.00218	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—BAX—hematologic cancer	2.51e-05	0.00217	CbGpPWpGaD
Alclometasone—Triamcinolone—NR3C1—hematologic cancer	2.51e-05	0.0243	CrCbGaD
Alclometasone—NR3C1—Circadian Clock—CREB1—hematologic cancer	2.51e-05	0.00217	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—IL4—hematologic cancer	2.51e-05	0.00217	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—IL13—hematologic cancer	2.46e-05	0.00213	CbGpPWpGaD
Alclometasone—NR3C1—Circadian Clock—CREBBP—hematologic cancer	2.44e-05	0.00211	CbGpPWpGaD
Alclometasone—Pruritus—Triamcinolone—hematologic cancer	2.39e-05	0.000681	CcSEcCtD
Alclometasone—Erythema—Doxorubicin—hematologic cancer	2.36e-05	0.000675	CcSEcCtD
Alclometasone—Rash—Etoposide—hematologic cancer	2.34e-05	0.000669	CcSEcCtD
Alclometasone—Dermatitis—Etoposide—hematologic cancer	2.34e-05	0.000669	CcSEcCtD
Alclometasone—Rash—Prednisolone—hematologic cancer	2.31e-05	0.00066	CcSEcCtD
Alclometasone—Dermatitis—Prednisolone—hematologic cancer	2.31e-05	0.00066	CcSEcCtD
Alclometasone—NR3C1—AP-1 transcription factor network—ESR1—hematologic cancer	2.3e-05	0.00199	CbGpPWpGaD
Alclometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—hematologic cancer	2.28e-05	0.00197	CbGpPWpGaD
Alclometasone—Prednisone—NR3C1—hematologic cancer	2.28e-05	0.0221	CrCbGaD
Alclometasone—NR3C1—Endoderm Differentiation—NOTCH1—hematologic cancer	2.27e-05	0.00197	CbGpPWpGaD
Alclometasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—hematologic cancer	2.27e-05	0.00196	CbGpPWpGaD
Alclometasone—NR3C1—lymph node—hematologic cancer	2.26e-05	0.0319	CbGeAlD
Alclometasone—Fluticasone Propionate—NR3C1—hematologic cancer	2.24e-05	0.0218	CrCbGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—GATA3—hematologic cancer	2.22e-05	0.00192	CbGpPWpGaD
Alclometasone—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	2.22e-05	0.00192	CbGpPWpGaD
Alclometasone—Infection—Methotrexate—hematologic cancer	2.21e-05	0.000632	CcSEcCtD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—hematologic cancer	2.17e-05	0.00188	CbGpPWpGaD
Alclometasone—Pruritus—Dexamethasone—hematologic cancer	2.17e-05	0.000618	CcSEcCtD
Alclometasone—Pruritus—Betamethasone—hematologic cancer	2.17e-05	0.000618	CcSEcCtD
Alclometasone—NR3C1—Regulation of Androgen receptor activity—MDM2—hematologic cancer	2.14e-05	0.00185	CbGpPWpGaD
Alclometasone—Rash—Triamcinolone—hematologic cancer	2.13e-05	0.000607	CcSEcCtD
Alclometasone—Dermatitis—Triamcinolone—hematologic cancer	2.12e-05	0.000607	CcSEcCtD
Alclometasone—NR3C1—Adipogenesis—STAT1—hematologic cancer	2.11e-05	0.00182	CbGpPWpGaD
Alclometasone—Prednisolone—NR3C1—hematologic cancer	2.1e-05	0.0203	CrCbGaD
Alclometasone—NR3C1—AP-1 transcription factor network—FOS—hematologic cancer	2.07e-05	0.00179	CbGpPWpGaD
Alclometasone—Infection—Epirubicin—hematologic cancer	2.07e-05	0.000591	CcSEcCtD
Alclometasone—NR3C1—AP-1 transcription factor network—CREB1—hematologic cancer	2.07e-05	0.00179	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—hematologic cancer	2.06e-05	0.00178	CbGpPWpGaD
Alclometasone—Betamethasone—NR3C1—hematologic cancer	2.06e-05	0.0199	CrCbGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—hematologic cancer	2.05e-05	0.00178	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—hematologic cancer	2.05e-05	0.00177	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—CCL2—hematologic cancer	2.02e-05	0.00175	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—ZNF552—hematologic cancer	2.02e-05	0.00174	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—hematologic cancer	1.99e-05	0.00172	CbGpPWpGaD
Alclometasone—Rash—Dexamethasone—hematologic cancer	1.93e-05	0.000551	CcSEcCtD
Alclometasone—Rash—Betamethasone—hematologic cancer	1.93e-05	0.000551	CcSEcCtD
Alclometasone—Dermatitis—Betamethasone—hematologic cancer	1.93e-05	0.00055	CcSEcCtD
Alclometasone—Dermatitis—Dexamethasone—hematologic cancer	1.93e-05	0.00055	CcSEcCtD
Alclometasone—Infection—Doxorubicin—hematologic cancer	1.92e-05	0.000547	CcSEcCtD
Alclometasone—NR3C1—Adipogenesis—STAT5A—hematologic cancer	1.9e-05	0.00164	CbGpPWpGaD
Alclometasone—Pruritus—Prednisone—hematologic cancer	1.89e-05	0.000538	CcSEcCtD
Alclometasone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	1.87e-05	0.00161	CbGpPWpGaD
Alclometasone—Hydrocortisone—ABCG2—hematologic cancer	1.86e-05	0.018	CrCbGaD
Alclometasone—NR3C1—Regulation of Androgen receptor activity—JUN—hematologic cancer	1.86e-05	0.00161	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—hematologic cancer	1.84e-05	0.00159	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—hematologic cancer	1.84e-05	0.00159	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—FOS—hematologic cancer	1.83e-05	0.00158	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—CREB1—hematologic cancer	1.82e-05	0.00158	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—hematologic cancer	1.79e-05	0.00155	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—NCOR1—hematologic cancer	1.78e-05	0.00154	CbGpPWpGaD
Alclometasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	1.78e-05	0.00154	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—hematologic cancer	1.78e-05	0.00153	CbGpPWpGaD
Alclometasone—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	1.77e-05	0.00153	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—CDKN2A—hematologic cancer	1.76e-05	0.00152	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—AR—hematologic cancer	1.76e-05	0.00152	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of Androgen receptor activity—MAPK8—hematologic cancer	1.76e-05	0.00152	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—FOXO1—hematologic cancer	1.74e-05	0.0015	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—IFNG—hematologic cancer	1.72e-05	0.00149	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of Androgen receptor activity—EP300—hematologic cancer	1.71e-05	0.00148	CbGpPWpGaD
Alclometasone—Rash—Prednisone—hematologic cancer	1.68e-05	0.00048	CcSEcCtD
Alclometasone—Dermatitis—Prednisone—hematologic cancer	1.68e-05	0.000479	CcSEcCtD
Alclometasone—NR3C1—Generic Transcription Pathway—RARA—hematologic cancer	1.67e-05	0.00144	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of Androgen receptor activity—SRC—hematologic cancer	1.67e-05	0.00144	CbGpPWpGaD
Alclometasone—NR3C1—Circadian Clock—EP300—hematologic cancer	1.66e-05	0.00144	CbGpPWpGaD
Alclometasone—Hydrocortisone—NR3C1—hematologic cancer	1.6e-05	0.0156	CrCbGaD
Alclometasone—NR3C1—Adipogenesis—FAS—hematologic cancer	1.6e-05	0.00138	CbGpPWpGaD
Alclometasone—Pruritus—Methotrexate—hematologic cancer	1.58e-05	0.00045	CcSEcCtD
Alclometasone—NR3C1—AP-1 transcription factor network—CDKN1B—hematologic cancer	1.56e-05	0.00135	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—NR0B2—hematologic cancer	1.55e-05	0.00134	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—HES1—hematologic cancer	1.55e-05	0.00134	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—IL10—hematologic cancer	1.54e-05	0.00133	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—IL2—hematologic cancer	1.53e-05	0.00132	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—CASC3—hematologic cancer	1.53e-05	0.00132	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—hematologic cancer	1.52e-05	0.00131	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—hematologic cancer	1.51e-05	0.0013	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—CCND1—hematologic cancer	1.49e-05	0.00129	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—JUN—hematologic cancer	1.49e-05	0.00129	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	1.48e-05	0.00128	CbGpPWpGaD
Alclometasone—Pruritus—Epirubicin—hematologic cancer	1.47e-05	0.000421	CcSEcCtD
Alclometasone—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	1.46e-05	0.00126	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—PTEN—hematologic cancer	1.44e-05	0.00124	CbGpPWpGaD
Alclometasone—Methylprednisolone—ABCB1—hematologic cancer	1.44e-05	0.0139	CrCbGaD
Alclometasone—Rash—Methotrexate—hematologic cancer	1.4e-05	0.000401	CcSEcCtD
Alclometasone—Dermatitis—Methotrexate—hematologic cancer	1.4e-05	0.000401	CcSEcCtD
Alclometasone—NR3C1—Generic Transcription Pathway—NCOR2—hematologic cancer	1.4e-05	0.00121	CbGpPWpGaD
Alclometasone—Dexamethasone—ABCG2—hematologic cancer	1.39e-05	0.0134	CrCbGaD
Alclometasone—NR3C1—AP-1 transcription factor network—EP300—hematologic cancer	1.37e-05	0.00119	CbGpPWpGaD
Alclometasone—Pruritus—Doxorubicin—hematologic cancer	1.36e-05	0.00039	CcSEcCtD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—IL2—hematologic cancer	1.35e-05	0.00116	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—hematologic cancer	1.32e-05	0.00114	CbGpPWpGaD
Alclometasone—Rash—Epirubicin—hematologic cancer	1.31e-05	0.000375	CcSEcCtD
Alclometasone—Dermatitis—Epirubicin—hematologic cancer	1.31e-05	0.000375	CcSEcCtD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—JUN—hematologic cancer	1.31e-05	0.00113	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hematologic cancer	1.28e-05	0.00111	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hematologic cancer	1.27e-05	0.0011	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—CREB1—hematologic cancer	1.26e-05	0.00109	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hematologic cancer	1.24e-05	0.00107	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—RB1—hematologic cancer	1.22e-05	0.00106	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hematologic cancer	1.22e-05	0.00106	CbGpPWpGaD
Alclometasone—NR3C1—Endoderm Differentiation—TGFB1—hematologic cancer	1.22e-05	0.00106	CbGpPWpGaD
Alclometasone—Rash—Doxorubicin—hematologic cancer	1.22e-05	0.000347	CcSEcCtD
Alclometasone—Dermatitis—Doxorubicin—hematologic cancer	1.22e-05	0.000347	CcSEcCtD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—EP300—hematologic cancer	1.21e-05	0.00104	CbGpPWpGaD
Alclometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	1.2e-05	0.00104	CbGpPWpGaD
Alclometasone—Dexamethasone—NR3C1—hematologic cancer	1.2e-05	0.0116	CrCbGaD
Alclometasone—NR3C1—AP-1 transcription factor network—MYC—hematologic cancer	1.2e-05	0.00103	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—TGFB1—hematologic cancer	1.19e-05	0.00103	CbGpPWpGaD
Alclometasone—Prednisone—ALB—hematologic cancer	1.15e-05	0.0112	CrCbGaD
Alclometasone—Prednisone—ABCB1—hematologic cancer	1.1e-05	0.0107	CrCbGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	1.09e-05	0.000942	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—hematologic cancer	1.08e-05	0.000936	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	1.06e-05	0.00092	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	1.06e-05	0.000919	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	1.06e-05	0.000917	CbGpPWpGaD
Alclometasone—Prednisolone—ABCB1—hematologic cancer	1.01e-05	0.00982	CrCbGaD
Alclometasone—Betamethasone—ABCB1—hematologic cancer	9.92e-06	0.00962	CrCbGaD
Alclometasone—NR3C1—Gene Expression—RARS—hematologic cancer	9.85e-06	0.000851	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—TP53—hematologic cancer	9.82e-06	0.000849	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	9.55e-06	0.000826	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	9.42e-06	0.000814	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—POLR3E—hematologic cancer	9.26e-06	0.000801	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—IL6—hematologic cancer	8.99e-06	0.000777	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	8.98e-06	0.000776	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—PARP1—hematologic cancer	8.91e-06	0.00077	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	8.86e-06	0.000766	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—CDKN1A—hematologic cancer	8.79e-06	0.00076	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—hematologic cancer	8.65e-06	0.000748	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	8.08e-06	0.000699	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	8.07e-06	0.000697	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—RARA—hematologic cancer	8.03e-06	0.000694	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—TET2—hematologic cancer	8.03e-06	0.000694	CbGpPWpGaD
Alclometasone—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	7.92e-06	0.000685	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—hematologic cancer	7.92e-06	0.000684	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—RPLP1—hematologic cancer	7.87e-06	0.000681	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—STAT3—hematologic cancer	7.84e-06	0.000678	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—JUN—hematologic cancer	7.83e-06	0.000677	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—MTR—hematologic cancer	7.79e-06	0.000673	CbGpPWpGaD
Alclometasone—Hydrocortisone—ABCB1—hematologic cancer	7.74e-06	0.00751	CrCbGaD
Alclometasone—NR3C1—Gene Expression—NR0B2—hematologic cancer	7.47e-06	0.000645	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—AR—hematologic cancer	7.45e-06	0.000644	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	7.41e-06	0.00064	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	7.38e-06	0.000638	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hematologic cancer	7.31e-06	0.000631	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—TGFB1—hematologic cancer	7.27e-06	0.000628	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—EP300—hematologic cancer	7.23e-06	0.000625	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—DNMT3A—hematologic cancer	7.12e-06	0.000616	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—ELL—hematologic cancer	7.02e-06	0.000607	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—CDKN2B—hematologic cancer	6.87e-06	0.000593	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	6.84e-06	0.000592	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—TNF—hematologic cancer	6.79e-06	0.000587	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—NCOR2—hematologic cancer	6.74e-06	0.000582	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—NCOR1—hematologic cancer	6.51e-06	0.000563	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—AGO2—hematologic cancer	6.21e-06	0.000537	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—H3F3B—hematologic cancer	6.09e-06	0.000526	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—DNMT3B—hematologic cancer	6.09e-06	0.000526	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	5.87e-06	0.000507	CbGpPWpGaD
Alclometasone—Dexamethasone—ABCB1—hematologic cancer	5.77e-06	0.0056	CrCbGaD
Alclometasone—NR3C1—Gene Expression—RPS14—hematologic cancer	5.57e-06	0.000481	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—NUP98—hematologic cancer	5.48e-06	0.000474	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—IL6—hematologic cancer	5.48e-06	0.000473	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—NUP214—hematologic cancer	5.28e-06	0.000457	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	5.13e-06	0.000444	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	5.11e-06	0.000442	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	5.06e-06	0.000438	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	4.94e-06	0.000427	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—HSPB1—hematologic cancer	4.87e-06	0.000421	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	4.87e-06	0.000421	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	4.73e-06	0.000409	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	4.72e-06	0.000408	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—SMC1A—hematologic cancer	4.66e-06	0.000403	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	4.65e-06	0.000402	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—H3F3A—hematologic cancer	4.57e-06	0.000395	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	4.48e-06	0.000387	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—EZH2—hematologic cancer	4.38e-06	0.000379	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—PARP1—hematologic cancer	4.29e-06	0.000371	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—HDAC2—hematologic cancer	4.14e-06	0.000358	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—FTCD—hematologic cancer	3.93e-06	0.00034	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PHYH—hematologic cancer	3.93e-06	0.00034	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GMPS—hematologic cancer	3.93e-06	0.00034	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SMPD3—hematologic cancer	3.6e-06	0.000311	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—AR—hematologic cancer	3.59e-06	0.00031	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—CDKN2B—hematologic cancer	3.31e-06	0.000286	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—DCK—hematologic cancer	3.15e-06	0.000272	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ASNS—hematologic cancer	3.15e-06	0.000272	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—B3GAT1—hematologic cancer	3.15e-06	0.000272	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—NCOR1—hematologic cancer	3.14e-06	0.000271	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HDC—hematologic cancer	2.98e-06	0.000258	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CDA—hematologic cancer	2.73e-06	0.000236	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	2.66e-06	0.00023	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PC—hematologic cancer	2.63e-06	0.000227	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GBA—hematologic cancer	2.54e-06	0.000219	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SLC35B2—hematologic cancer	2.54e-06	0.000219	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—MAPK14—hematologic cancer	2.51e-06	0.000217	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—ESR1—hematologic cancer	2.46e-06	0.000213	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—NOTCH1—hematologic cancer	2.38e-06	0.000206	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—MTAP—hematologic cancer	2.32e-06	0.0002	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—CREBBP—hematologic cancer	2.16e-06	0.000187	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—FHL2—hematologic cancer	2.07e-06	0.000179	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—AGRN—hematologic cancer	2.03e-06	0.000175	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—IDH2—hematologic cancer	1.92e-06	0.000166	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HMMR—hematologic cancer	1.92e-06	0.000166	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.81e-06	0.000156	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ACP5—hematologic cancer	1.76e-06	0.000152	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CA9—hematologic cancer	1.76e-06	0.000152	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.73e-06	0.00015	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—IDH1—hematologic cancer	1.65e-06	0.000143	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—TXN—hematologic cancer	1.63e-06	0.000141	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.63e-06	0.000141	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.63e-06	0.000141	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.6e-06	0.000138	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.54e-06	0.000133	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.49e-06	0.000129	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.49e-06	0.000129	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.46e-06	0.000126	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NUP98—hematologic cancer	1.41e-06	0.000122	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.37e-06	0.000118	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.37e-06	0.000118	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NUP214—hematologic cancer	1.36e-06	0.000117	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—MTR—hematologic cancer	1.33e-06	0.000115	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.33e-06	0.000115	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—MAPK3—hematologic cancer	1.32e-06	0.000114	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ENO2—hematologic cancer	1.31e-06	0.000113	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—MYC—hematologic cancer	1.28e-06	0.000111	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.27e-06	0.000109	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SDC1—hematologic cancer	1.24e-06	0.000107	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CD44—hematologic cancer	1.05e-06	9.1e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NQO1—hematologic cancer	1.05e-06	9.1e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYCS—hematologic cancer	9.96e-07	8.61e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	9.9e-07	8.56e-05	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—AKT1—hematologic cancer	8.88e-07	7.68e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTP1—hematologic cancer	8.78e-07	7.59e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ABCB1—hematologic cancer	8.31e-07	7.18e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTM1—hematologic cancer	8.07e-07	6.97e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NCOR1—hematologic cancer	8.07e-07	6.97e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—MTHFR—hematologic cancer	7.13e-07	6.16e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	5.99e-07	5.18e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CREBBP—hematologic cancer	5.55e-07	4.8e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	5.27e-07	4.55e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ALB—hematologic cancer	5.2e-07	4.49e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	4.97e-07	4.3e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	4.59e-07	3.97e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PTEN—hematologic cancer	3.97e-07	3.43e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—EP300—hematologic cancer	3.78e-07	3.27e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.8e-07	2.42e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—AKT1—hematologic cancer	2.29e-07	1.98e-05	CbGpPWpGaD
